Published in Hypertension on November 24, 2003
Self-monitoring of Blood Pressure in Primary Care | NCT00717665
Effect of social deprivation on blood pressure monitoring and control in England: a survey of data from the quality and outcomes framework. BMJ (2008) 3.80
Treatment strategies for resistant arterial hypertension. Dtsch Arztebl Int (2011) 3.32
Associations between Borg's rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol (2012) 2.51
Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis. BMJ (2005) 2.41
Gender differences in health: results from SHARE, ELSA and HRS. Eur J Public Health (2010) 2.15
Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry. Clin Res Cardiol (2013) 1.78
The Canadian Hypertension Education Program--a unique Canadian initiative. Can J Cardiol (2006) 1.76
Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study. Int J Hypertens (2010) 1.74
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2009) 1.64
Cardiovascular disease and associated risk factors in Cuba: prospects for prevention and control. Am J Public Health (2005) 1.52
Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health (2009) 1.51
Supporting self-care in general practice. Br J Gen Pract (2007) 1.50
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2007) 1.49
Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees. BMC Cardiovasc Disord (2010) 1.45
Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006. Can J Cardiol (2008) 1.43
Barriers to adherence to hypertension guidelines among GPs in southern Sweden: a survey. Scand J Prim Health Care (2008) 1.41
Altered blood pressure progression in the community and its relation to clinical events. Arch Intern Med (2008) 1.38
Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky Medication Adherence Scale. PLoS One (2013) 1.37
1999-2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS One (2012) 1.35
Cardiovascular disease, diabetes and established risk factors among populations of sub-Saharan African descent in Europe: a literature review. Global Health (2009) 1.34
Cognitive health among older adults in the United States and in England. BMC Geriatr (2009) 1.32
Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ (2013) 1.31
Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol (2011) 1.28
Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc (2014) 1.26
Resistant hypertension--its identification and epidemiology. Nat Rev Nephrol (2012) 1.26
Cardiovascular burden and related risk factors among Nunavik (Quebec) Inuit: insights from baseline findings in the circumpolar Inuit health in transition cohort study. Can J Cardiol (2010) 1.24
Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial. BMJ (2007) 1.24
Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation (2010) 1.22
Optimizing blood pressure control through the use of fixed combinations. Vasc Health Risk Manag (2010) 1.17
Screening, treatment, and control of hypertension in US private physician offices, 2003-2004. Hypertension (2008) 1.16
A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile. Int J Clin Pract (2008) 1.16
Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review. Cardiovasc Diabetol (2009) 1.14
Novel therapeutic targets for hypertension. Nat Rev Cardiol (2010) 1.13
Telemanagement of hypertension: a qualitative assessment of patient and physician preferences. Can J Cardiol (2007) 1.13
The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. Int J Clin Pract (2008) 1.11
Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens (2014) 1.11
Sticky knowledge: a possible model for investigating implementation in healthcare contexts. Implement Sci (2007) 1.09
Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study. Nutr Metab Cardiovasc Dis (2009) 1.08
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2010) 1.07
Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol (2008) 1.05
Symptoms of depression and anxiety and adherence to antihypertensive medication. Am J Hypertens (2012) 1.03
Carvedilol in hypertension treatment. Vasc Health Risk Manag (2008) 1.02
Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan. BMC Health Serv Res (2008) 1.01
The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review. BMC Fam Pract (2014) 1.01
US mortality in an international context: age variations. Popul Dev Rev (2010) 1.00
Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study. J Gen Intern Med (2008) 0.99
Prevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg project. Scand J Prim Health Care (2012) 0.99
Stroke among male professional drivers in Denmark, 1994-2003. Occup Environ Med (2006) 0.99
Lifestyle and psychosocial risk factors predict non-adherence to medication. Ann Behav Med (2010) 0.98
Guidelines from the British Hypertension Society. BMJ (2004) 0.98
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens (2014) 0.97
Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr (2006) 0.96
Level of unawareness and management of diabetes, hypertension, and dyslipidemia among adults in Luxembourg: findings from ORISCAV-LUX study. PLoS One (2013) 0.95
Health-related quality of life and blood pressure control in hypertensive patients with and without complications. Clinics (Sao Paulo) (2009) 0.93
Why do Americans have shorter life expectancy and worse health than do people in other high-income countries? Annu Rev Public Health (2014) 0.93
Blood pressure management in a cohort of hypertensive patients in Germany treated by cardiologists. Clin Res Cardiol (2011) 0.93
Use of carvedilol in hypertension: an update. Vasc Health Risk Manag (2012) 0.92
Organisational factors in relation to control of blood pressure: an observational study. Br J Gen Pract (2005) 0.92
A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens (2008) 0.91
Scaling up chronic disease prevention interventions in lower- and middle-income countries. Annu Rev Public Health (2013) 0.91
Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis. PLoS Med (2016) 0.91
Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension. Vasc Health Risk Manag (2009) 0.91
Association of occupation with prevalent hypertension in an elderly East German population: an exploratory cross-sectional analysis. Int Arch Occup Environ Health (2010) 0.90
A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice. Vasc Health Risk Manag (2007) 0.90
CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid sinus stimulation. J Physiol (2014) 0.89
Olmesartan/amlodipine: a review of its use in the management of hypertension. Vasc Health Risk Manag (2011) 0.89
Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign. Vasc Health Risk Manag (2013) 0.88
The quality of primary care in a country with universal health care coverage. J Gen Intern Med (2011) 0.88
Adherence level of antihypertensive agents in coronary artery disease. Br J Clin Pharmacol (2010) 0.87
Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care: a population-based follow-up study in the Skaraborg Project. Scand J Prim Health Care (2007) 0.87
Hypertension: empirical evidence and implications in 2014. Open Heart (2014) 0.87
Patient-related barriers to hypertension control in a Nigerian population. Int J Gen Med (2014) 0.87
Protocol for a randomised controlled trial of telemonitoring and self-management in the control of hypertension: telemonitoring and self-management in hypertension. [ISRCTN17585681]. BMC Cardiovasc Disord (2009) 0.87
Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates. PLoS One (2013) 0.86
Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom. Br J Clin Pharmacol (2008) 0.86
Regional variations in not treating diagnosed hypertension in Canada. Can J Cardiol (2010) 0.86
Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation. Cardiovasc Diabetol (2012) 0.86
Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010. Clin Res Cardiol (2010) 0.85
Electronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care. Scand J Prim Health Care (2007) 0.85
Diabetic hypertensive control and treatment: a descriptive report from the audit diabetes control and management (adcm) registry. Malays Fam Physician (2010) 0.85
Implementation of guidelines for the management of arterial hypertension. The impulsion study. Open Cardiovasc Med J (2009) 0.85
Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications? PLoS One (2015) 0.84
Diverging trends in cardiovascular morbidity and mortality in a low risk population. Eur J Epidemiol (2009) 0.84
Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients. PLoS One (2012) 0.84
Osmotically driven drug delivery through remote-controlled magnetic nanocomposite membranes. Biomicrofluidics (2015) 0.84
A quasi-experimental test of an intervention to increase the use of thiazide-based treatment regimens for people with hypertension. Implement Sci (2007) 0.83
Persistence to antihypertensive drug treatment in Swedish primary healthcare. Eur J Clin Pharmacol (2013) 0.83
Primary care of patients with high cardiovascular risk : Blood pressure, lipid and diabetic target levels and their achievement in Hungary. Wien Klin Wochenschr (2013) 0.82
An evaluation of a clinical pharmacy-directed intervention on blood pressure control. Pharm Pract (Granada) (2006) 0.82
Hypertension among adults in a deprived urban area of Peru - undiagnosed and uncontrolled? BMC Res Notes (2008) 0.82
Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension. Int J Hypertens (2012) 0.82
The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series. CMAJ (2005) 0.82
Racial differences in response to antihypertensive therapy: does one size fits all? Int J Prev Med (2010) 0.82
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. Vasc Health Risk Manag (2008) 0.82
Prevalence of hypertension, its awareness and control in adult population in Japan. J Hum Hypertens (2004) 0.81
Review of the state of renal nerve ablation for patients with severe and resistant hypertension. J Am Soc Hypertens (2013) 0.81
Self monitoring of high blood pressure. BMJ (2005) 0.81
Management of hypertension in patients with diabetes mellitus. Exp Clin Cardiol (2010) 0.80
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet (2007) 14.99
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol (2004) 9.43
Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA (2003) 9.06
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12
A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. Am J Hum Genet (2006) 7.89
Admixture mapping for hypertension loci with genome-scan markers. Nat Genet (2005) 6.78
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension (2011) 5.73
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. JAMA (2013) 4.82
Physical activity does not influence obesity risk: time to clarify the public health message. Int J Epidemiol (2013) 4.71
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol (2009) 4.43
Association mapping, using a mixture model for complex traits. Genet Epidemiol (2002) 3.95
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Kidney Int (2013) 3.42
Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension (2009) 3.40
From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci U S A (2008) 3.39
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11
Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension (2005) 3.07
A unified association analysis approach for family and unrelated samples correcting for stratification. Am J Hum Genet (2008) 3.00
Sex differences in stroke epidemiology: a systematic review. Stroke (2009) 2.99
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J (2004) 2.85
A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. Am J Hypertens (2003) 2.76
Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health Suppl (2003) 2.72
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 2.70
Neighborhood characteristics and hypertension. Epidemiology (2008) 2.70
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med (2014) 2.64
Community-based interventions to promote blood pressure control in a developing country: a cluster randomized trial. Ann Intern Med (2009) 2.64
Measuring nicotine intake in population surveys: comparability of saliva cotinine and plasma cotinine estimates. Nicotine Tob Res (2003) 2.62
The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health (2008) 2.58
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am J Hum Genet (2012) 2.53
Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from a cluster-randomized, factorial-controlled trial. Circulation (2011) 2.44
World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol (2010) 2.38
The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts. PLoS Genet (2007) 2.35
Multiple genes for essential-hypertension susceptibility on chromosome 1q. Am J Hum Genet (2006) 2.34
Common single-nucleotide polymorphisms act in concert to affect plasma levels of high-density lipoprotein cholesterol. Am J Hum Genet (2007) 2.28
Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res (2008) 2.24
Linkage analysis of a complex disease through use of admixed populations. Am J Hum Genet (2004) 2.21
Corin I555(P568) allele is associated with enhanced cardiac hypertrophic response to increased systemic afterload. Hypertension (2007) 2.17
Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes (2004) 2.17
The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes. Diabetes Care (2013) 2.07
Reverse causation and illness-related weight loss in observational studies of body weight and mortality. Am J Epidemiol (2010) 1.99
Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality. Ann Intern Med (2003) 1.98
Night-time heart rate cut-off point definition by resting office tachycardia in untreated hypertensive patients: data of the Spanish ABPM registry. J Hypertens (2014) 1.97
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet (2012) 1.96
Poststroke fatigue: a 2-year follow-up study of stroke patients in Sweden. Stroke (2002) 1.95
Genetics. The science and business of genetic ancestry testing. Science (2007) 1.95
Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project. Stroke (2003) 1.93
Blood pressure in Canadian adults. Health Rep (2010) 1.93
Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis (2008) 1.91
Genome-wide association of anthropometric traits in African- and African-derived populations. Hum Mol Genet (2010) 1.90
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. Diabetes Care (2009) 1.89
High remaining risk in poorly treated hypertension: the 'rule of halves' still exists. J Hypertens (2002) 1.89
Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol (2005) 1.88
Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring) (2008) 1.87
Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol (2011) 1.87
A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet (2002) 1.87
Impact of energy intake, physical activity, and population-wide weight loss on cardiovascular disease and diabetes mortality in Cuba, 1980-2005. Am J Epidemiol (2007) 1.87
Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol (2007) 1.84
Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation (2005) 1.84
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Vitamin D concentrations among people aged 65 years and over living in private households and institutions in England: population survey. Age Ageing (2005) 1.81
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J (2009) 1.79
Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke (2003) 1.78
Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet (2011) 1.77
[PREVENCAT study: control of cardiovascular risk in primary care]. Med Clin (Barc) (2005) 1.76
German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave. BMC Public Health (2012) 1.72
Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs. J Hypertens (2012) 1.71
Self-reported depression and use of antidepressants after stroke: a national survey. Stroke (2004) 1.70
Sex differences in stroke care and outcome in the Swedish national quality register for stroke care. Stroke (2008) 1.70
Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol (2009) 1.68
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67
Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens (2006) 1.64
Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis (2010) 1.64
Self-rated ill-health strengthens the effect of biomedical risk factors in predicting stroke, especially for men -- an incident case referent study. J Hypertens (2003) 1.64
Usual sleep duration and cognitive function in older adults in Spain. J Sleep Res (2009) 1.63
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus. Kidney Int (2012) 1.63
Adverse renal consequences of obesity. Am J Physiol Renal Physiol (2008) 1.62
Association between blood pressure and resting energy expenditure independent of body size. Hypertension (2004) 1.62
Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. PLoS Genet (2011) 1.60
Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens (2007) 1.60
The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension (2004) 1.59
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial. Eur Heart J (2006) 1.58
Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med (2005) 1.57
Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am J Hum Genet (2013) 1.55
Race and ancestry in biomedical research: exploring the challenges. Genome Med (2009) 1.55
Socioeconomic position in childhood and cardiovascular risk factors in older Spanish people. Int J Epidemiol (2004) 1.54